.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Find suppliers and generic API sources
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Deloitte
Novartis
Argus Health
Chubb
AstraZeneca
UBS
Cantor Fitzgerald
Julphar
Farmers Insurance

Generated: July 23, 2017

DrugPatentWatch Database Preview

Sutilains - Generic Drug Details

« Back to Dashboard

What are the generic sources for sutilains and what is the scope of sutilains freedom to operate?

Sutilains
is the generic ingredient in one branded drug marketed by Abbott and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Summary for Generic Name: sutilains

Tradenames:1
Patents:1
Applicants:1
NDAs:1
Drug Prices:see low prices
DailyMed Link:sutilains at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbott
TRAVASE
sutilains
OINTMENT;TOPICAL012828-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: sutilains

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbott
TRAVASE
sutilains
OINTMENT;TOPICAL012828-001Approved Prior to Jan 1, 19823,409,719► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Julphar
Cipla
Daiichi Sankyo
McKesson
Cantor Fitzgerald
UBS
McKinsey
Novartis
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot